Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters
Pieter A. Cohen, Bharathi Avula, Kumar Katragunta, Ikhlas A. Khan
Abstract
This study examines the frequency of product recalls and the presence of FDA-prohibited drugs in supplements after FDA warning letters.
Topics & Concepts
MedicineAdvertisingInternet privacyEnvironmental healthBusinessComputer scienceConsumer Attitudes and Food LabelingPharmaceutical studies and practicesPharmacology and Obesity Treatment